Skip to main content
Semler Scientific, Inc. logo

Semler Scientific, Inc. — Investor Relations & Filings

Ticker · SMLR ISIN · US81684M1045 LEI · 549300ZHL16S29QTW485 US Professional, scientific and technical activities
Open in API
Filings indexed 864 across all filing types
Latest filing 2014-11-03 Regulatory Filings
Country US United States of America
Listing US SMLR

About Semler Scientific, Inc.

https://www.semlerscientific.com/

Semler Scientific, Inc. is a company that develops, manufactures, and markets technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. Its primary focus is on products and services that support the early detection and treatment of chronic diseases. The company's flagship product is a patented, FDA-cleared system that provides a rapid, point-of-care test to aid in the diagnosis of peripheral artery disease (PAD). In addition to its healthcare technology operations, the company has adopted a corporate strategy to acquire and hold bitcoin as its primary treasury reserve asset.

Recent filings

Filing Released Lang Actions
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The text specifically mentions Item 2.02, which is "Results of Operations and Financial Condition," and states that a press release announcing financial results for the third quarter ended September 30, 2014, is furnished as an exhibit. The document itself does not contain detailed financial statements or substantive financial data but rather references the press release. The length of the document is 3357 characters, which is relatively short and consistent with an announcement rather than a full financial report. According to the rules, if a document is short and announces or furnishes a report (like a press release) without containing the full report itself, it should be classified as a Regulatory Filing (RNS) rather than an Interim Report (IR) or Earnings Release (ER). Although the content relates to quarterly financial results, the document is a Form 8-K current report announcing the results, not the results themselves. Therefore, the appropriate classification is Regulatory Filings (RNS).
2014-11-03 English
FORM 10-Q
Interim / Quarterly Report Q3 2014
2014-11-03 English
FORM S-8
Regulatory Filings Classification · 95% confidence The document is a Form S-8 Registration Statement filed with the SEC. Form S-8 is used for registering securities to be offered under employee benefit plans, such as stock incentive plans. The document includes details about the securities to be registered, indemnification of directors and officers, incorporation by reference of other filings, and signatures of company officers. It is not a financial report, earnings release, or management discussion, nor is it an announcement or proxy statement. It is a regulatory filing related to securities registration under the Securities Act of 1933. Therefore, the most appropriate classification is Regulatory Filings (RNS). The document length and content confirm it is a full filing, not a brief announcement or certification.
2014-09-23 English
OWNERSHIP DOCUMENT
Director's Dealing
2014-09-13 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content includes approval of a stock incentive plan by shareholders, details about the plan, and references to voting results. The document is relatively short (3539 characters) and does not contain comprehensive financial statements or detailed financial analysis. It primarily reports on a compensatory arrangement and shareholder vote results. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement and does not fit into more specific categories like Annual Report, Earnings Release, or Proxy Solicitation. The presence of voting results might suggest DVA, but since it is part of a Form 8-K and includes compensatory arrangements, RNS is more appropriate as it is a general regulatory filing reporting material events.
2014-09-02 English
DEFINITIVE INFORMATION STATEMENT
Proxy Solicitation & Information Statement Classification · 95% confidence The document is titled 'DEF 14C' and is described as a 'Definitive Information Statement' pursuant to Section 14(c) of the Securities Exchange Act of 1934. It relates to a written consent by majority stockholders approving the adoption of a 2014 Stock Incentive Plan. The document is informational and is not a proxy solicitation but a notice of corporate action by written consent. It includes detailed information about the stock incentive plan and the voting process but does not contain financial statements or earnings data. The DEF 14C form is used for definitive information statements, which are materials sent to shareholders to provide information and request votes for meetings or consents. This matches the definition of Proxy Solicitation & Information Statement (PSI). The document length is substantial and contains the full information statement, not just an announcement or a brief notice, so it is not an RPA or RNS. Therefore, the correct classification is PSI with high confidence.
2014-09-02 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.